Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

FDA knows that Ceplene prevent relapse!!!

|Includes: EpiCept Corporation (EPCT)

I have some questions about a drug that comes from EpiCept in the U.S..this applies Ceplene which is a hole in the treatment of relapse of AML is Approved and launched in Europe by the EMA.
On 17 August, EpiCept a refusal to accept the NDA application from EpiCept.
So now to my question has not Americans entitled to the same drugs that are approved of Europe and extends the life and have a medical need.
The most alarming is that there is no other product on the market.
So I find it strange for Americans not to be treated with Ceplene If it saves lives.
FDA knows that Ceplene prevent relapse, but they want to see how it works.
Then it feels like to approve Ceplene so that patients can get treatment and
requires that the Company should demonstrate how it operates and works with a low dose of IL-2. I am writing to you to help sick American patients who have received one of the world's most deadly disease AML, that they are entitled to Ceplene and not have to wait before they Can be treated.
Hematologists from across Europe have called the treatment as a paradigm shift.